Web-based support for women living with HIV/AIDS
Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement
NA · University of California, San Diego · NCT05509959
This study is testing a new online support program to see if it can help women living with HIV/AIDS who have faced violence stick to their medication and improve their health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 360 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of California, San Diego (other) |
| Locations | 1 site (La Jolla, California) |
| Trial ID | NCT05509959 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of Women SHINE, a web-based intervention designed to provide trauma-informed peer navigation and social support for women living with HIV/AIDS who have experienced interpersonal violence. The study will enroll 360 women who are non-adherent to antiretroviral therapy (ART) and will randomly assign them to either the Women SHINE intervention or a control group. Participants in the intervention will receive personalized support through one-on-one sessions, group psychoeducation, and access to online resources over four months. The goal is to improve ART adherence and overall health outcomes for these women.
Who should consider this trial
Good fit: Ideal candidates are cisgender women aged 18 and older, diagnosed with HIV, who have experienced interpersonal violence and are currently prescribed ART but are non-adherent.
Not a fit: Patients who are not cisgender women, have a recent history of ART adherence, or do not have access to an internet browser may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve ART adherence and health outcomes for women living with HIV/AIDS who have faced trauma.
How similar studies have performed: Previous studies have shown that peer navigation and psychoeducation can improve health outcomes for women living with HIV, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cisgender female * Diagnosis of HIV by a physician, healthcare provider, or community health worker * Aged 18 years or older * Speaking and reading English or Spanish * Adulthood experiences of interpersonal violence * Currently prescribed ART * Self-report of \<90% past-month ART adherence * Not currently participating in another adherence intervention * Access to an internet browser Exclusion Criteria: * Unwillingness to participate in the intervention * Transgender female * No diagnosis of HIV by a physician, healthcare provider, or community health worker * Aged less than 18 years * Not speaking and reading English or Spanish * Not currently prescribed ART * Self-report of \>= 90% past-month ART adherence * Currently participating in another adherence intervention * No access to an internet browser * Cognitive impairment limiting the ability to provide informed consent * Experiencing only childhood experiences of interpersonal violence * Inability to safely participate in the study based on secondary screener
Where this trial is running
La Jolla, California
- The Regents of the Univ. of Calif., U.C. San Diego — La Jolla, California, United States (RECRUITING)
Study contacts
- Principal investigator: Jamila K Stockman, PhD, MPH — University of California, San Diego
- Study coordinator: Cassandra Cyr, MPH
- Email: clcyr@health.ucsd.edu
- Phone: (858) 534-7979
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: HIV/AIDS, HIV Care Continuum, Psychoeducation